Literature DB >> 9662409

A search for type 1 diabetes susceptibility genes in families from the United Kingdom.

C A Mein1, L Esposito, M G Dunn, G C Johnson, A E Timms, J V Goy, A N Smith, L Sebag-Montefiore, M E Merriman, A J Wilson, L E Pritchard, F Cucca, A H Barnett, S C Bain, J A Todd.   

Abstract

Genetic analysis of a mouse model of major histocompatability complex (MHC)-associated autoimmune type 1 (insulin-dependent) diabetes mellitus (IDDM) has shown that the disease is caused by a combination of a major effect at the MHC and at least ten other susceptibility loci elsewhere in the genome. A genome-wide scan of 93 affected sibpair families (ASP) from the UK (UK93) indicated a similar genetic basis for human type 1 diabetes, with the major genetic component at the MHC locus (IDDM1) explaining 34% of the familial clustering of the disease (lambda(s)=2.5; refs 3,4). In the present report, we have analysed a further 263 multiplex families from the same population (UK263) to provide a total UK data set of 356 ASP families (UK356). Only four regions of the genome outside IDDM1/MHC, which was still the only major locus detected, were not excluded at lambda(s)=3 and lod=-2, of which two showed evidence of linkage: chromosome 10p13-p11 (maximum lod score (MLS)=4.7, P=3x10(-6), lambda(s)=1.56) and chromosome 16q22-16q24 (MLS=3.4, P=6.5x10(-5), lambda(s)=1.6). These and other novel regions, including chromosome 14q12-q21 and chromosome 19p13-19q13, could potentially harbour disease loci but confirmation and fine mapping cannot be pursued effectively using conventional linkage analysis. Instead, more powerful linkage disequilibrium-based and haplotype mapping approaches must be used; such data is already emerging for several type 1 diabetes loci detected initially by linkage.

Entities:  

Mesh:

Year:  1998        PMID: 9662409     DOI: 10.1038/991

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  62 in total

1.  Replication of linkage studies of complex traits: an examination of variation in location estimates.

Authors:  S B Roberts; C J MacLean; M C Neale; L J Eaves; K S Kendler
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

2.  On a randomization procedure in linkage analysis.

Authors:  H Zhao; K R Merikangas; K K Kidd
Journal:  Am J Hum Genet       Date:  1999-11       Impact factor: 11.025

3.  A general conditional-logistic model for affected-relative-pair linkage studies.

Authors:  J M Olson
Journal:  Am J Hum Genet       Date:  1999-12       Impact factor: 11.025

Review 4.  Genetic predisposition to IDDM.

Authors:  S Caillat-Zucman; J F Bach
Journal:  Clin Rev Allergy Immunol       Date:  2000-12       Impact factor: 8.667

5.  Age and sex based genetic locus heterogeneity in type 1 diabetes.

Authors:  A D Paterson; A Petronis
Journal:  J Med Genet       Date:  2000-03       Impact factor: 6.318

6.  Multilocus linkage tests based on affected relative pairs.

Authors:  H J Cordell; G C Wedig; K B Jacobs; R C Elston
Journal:  Am J Hum Genet       Date:  2000-03-21       Impact factor: 11.025

7.  Multipoint linkage analysis of the pseudoautosomal regions, using affected sibling pairs.

Authors:  J Dupuis; P Van Eerdewegh
Journal:  Am J Hum Genet       Date:  2000-06-26       Impact factor: 11.025

8.  Effects of stratification in the analysis of affected-sib-pair data: benefits and costs.

Authors:  S M Leal; J Ott
Journal:  Am J Hum Genet       Date:  2000-02       Impact factor: 11.025

9.  Mining SNPs from EST databases.

Authors:  L Picoult-Newberg; T E Ideker; M G Pohl; S L Taylor; M A Donaldson; D A Nickerson; M Boyce-Jacino
Journal:  Genome Res       Date:  1999-02       Impact factor: 9.043

10.  Seven regions of the genome show evidence of linkage to type 1 diabetes in a consensus analysis of 767 multiplex families.

Authors:  N J Cox; B Wapelhorst; V A Morrison; L Johnson; L Pinchuk; R S Spielman; J A Todd; P Concannon
Journal:  Am J Hum Genet       Date:  2001-08-15       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.